Transcriptomics

Dataset Information

0

ARID1B loss drives sorafenib resistance through transcriptional reprogramming in hepatocellular carcinoma


ABSTRACT: mRNA-seq was performed in HepG2 hepatocellular carcinoma cells to characterize transcriptional changes driven by ARID1B loss under sorafenib treatment. Wild-type (WT) and ARID1B-knockout (ARID1B-KO) HepG2 cells were treated with sorafenib (5 µM, 48 h) or DMSO vehicle, with three biological replicates per condition. DESeq2 interaction model identified ARID1B-dependent transcriptional responses to sorafenib. Preprint: https://doi.org/10.64898/2026.06.11.731725

ORGANISM(S): Homo sapiens

PROVIDER: GSE335769 | GEO | 2026/06/19

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2026-06-19 | GSE335770 | GEO
2026-06-19 | GSE335773 | GEO
2026-06-03 | GSE331457 | GEO
2026-06-03 | GSE330014 | GEO
2026-06-03 | GSE329957 | GEO
2026-06-03 | GSE329951 | GEO
2023-12-01 | GSE225537 | GEO
2021-01-04 | GSE164159 | GEO
| PRJEB30505 | ENA
2026-06-03 | GSE330015 | GEO